Stay up-to-date with the latest news and information from the drug testing industry by subscribing to Results, our monthly newsletter.
Your Privacy Choices | Privacy Notices | Privacy Shield | Terms | Language Assistance / Non-Discrimination Notice | Asistencia de Idiomas / Aviso de no Discriminación | 語言協助 / 不䈚視通知
Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks — ® and ™ — are the property of their respective owners. © 2000-2024 Quest Diagnostics Incorporated. All rights reserved.
DATIA focus is the quarterly publication of the Drug & Alcohol Testing Industry Association (DATIA). DATIA focus features a regular, popular column titled, “Name that Drug” where interesting facts about a mystery drug are described in advance of the name being revealed.
The latest edition of “Name that Drug” was written by Dr. Richard Simpson, Science Director at Quest Diagnostics, and is entitled, “Semi-Synthetic, Highly Prolific.” Give the article a read and see if you can solve the “Name that Drug” mystery in the fall edition of DATIA focus.
For more information about drug testing, visit our website.